Nilox Mini (Nitroxoline)

Nitroxoline, the active ingredient in Nilox Mini, is an antibacterial presented as an oral dosage form for oral use. It is indicated for the treatment of urinary tract infections in adults and children where appropriate. GNH USA supplies Nilox Mini as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nitroxoline is used to manage infections of the urinary tract by targeting bacterial growth. - Uncomplicated urinary tract infection: reduces bacterial load and alleviates symptoms. - Acute cystitis: helps eradicate the causative organisms and shortens disease duration. - Pyelonephritis: contributes to bacterial clearance in upper urinary tract infection.

Nitroxoline may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Vomiting: occasional episodes after dosing. - Abdominal pain: cramp‑like discomfort. - Headache: transient mild headache. - Dyspepsia: indigestion or heartburn. - Rash: mild skin erythema.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Hepatic enzyme elevation: signs of liver irritation or injury. - Blood dyscrasias: rare cases of neutropenia or thrombocytopenia. - Stevens‑Johnson syndrome: severe skin and mucous membrane disorder.

Before prescribing Nilox Mini, clinicians should consider several safety aspects. - Renal impairment: monitor renal function and adjust therapy if needed. - Hepatic dysfunction: use with caution and observe liver enzymes. - Pregnancy: safety category unknown; avoid unless benefits outweigh risks. - Breastfeeding: unknown excretion in milk; consider alternative therapy. - Elderly patients: increased susceptibility to adverse effects; monitor closely. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Nitroxoline can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Metal cations (iron, calcium, magnesium supplements): may markedly decrease nitroxoline absorption. - Anticoagulants (warfarin): potential enhancement of bleeding risk.

Moderate Interactions (Monitor Closely): - NSAIDs: may increase risk of renal toxicity when combined. - Diuretics: possible electrolyte disturbances. - Other antibiotics (e.g., quinolones): additive antimicrobial toxicity may occur.